Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 17,393 | 9,625 | 10,372 | 305 | 33 |
| Operating Income | -17,393 | -9,625 | -10,372 | -305 | -33 |
| Other Income | 15,359 | 3,349 | -5,906 | 0 | 0 |
| Pre-tax Income | -2,034 | -6,276 | -16,278 | -305 | -33 |
| Net Income Continuous | -2,034 | -6,276 | -16,278 | -305 | -33 |
| Net Income | $-2,034 | $-6,276 | $-16,278 | $-305 | $-33 |
| EPS Basic Total Ops | -2.40 | -9.20 | -61.80 | -1.20 | -0.20 |
| EPS Basic Continuous Ops | -2.49 | -9.14 | -61.94 | -1.20 | -0.13 |
| EPS Diluted Total Ops | -2.40 | -9.20 | -61.80 | -1.20 | -0.20 |
| EPS Diluted Continuous Ops | -2.49 | -9.14 | -61.94 | -1.20 | -0.13 |
| EBITDA(a) | $-17,419 | $-9,650 | $-10,372 | $-305 | $-33 |